⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12425843 | 1.00 | — | — | |
| SCHEMBL3018675 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL27803981 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL8036195 | 0.98 | — | — | |
| SCHEMBL4999678 | 0.93 | — | — | |
| SCHEMBL25015337 | 0.91 | CYP1A2 (0.38) | — | |
| SCHEMBL16511457 | 0.91 | CYP1A2 (0.38) | — | |
| Formic Acid SCHEMBL31221547 | 0.88 | CPN1 (0.42) | — | |
| Formic Acid SCHEMBL28924639 | 0.88 | CPN1 (0.42) | — | |
| Formic Acid SCHEMBL29067106 | 0.88 | CPN1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 708 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122154-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2025-04-17 | — | — | US | claimed |
| CN-119663385-A | Leveling agent and preparation method thereof, copper electroplating solution and copper electroplating method | 广东东硕科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| US-20240239745-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-07-18 | — | — | US | claimed |
| EP-4375280-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-05-29 | — | — | EP | claimed |
| EP-4371985-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-05-22 | — | — | EP | claimed |
| CN-117836290-A | Synthesis method of bilirubin | 株式会社毕丽斯 | 2024-04-05 | — | — | CN | claimed |
| CN-117813301-A | Synthesis method of bilirubin | 株式会社毕丽斯 | 2024-04-02 | — | — | CN | claimed |
| CN-117142974-A | Method for preparing alpha, beta unsaturated amide derivative | 中国科学院大连化学物理研究所 | 2023-12-01 | — | — | CN | claimed |
| CN-116425635-A | Method for synthesizing nifedipine intermediate by using combined catalyst | 合肥立方制药股份有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-111233672-B | Method for synthesizing nifedipine intermediate by using combined catalyst | 合肥立方制药股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| US-5574037-A | MODULATED BY SINO-ATRIAL NODE, ANTIISCHEMIC AGENT | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1996-11-12 | — | — | US | claimed |
| EP-0431856-B1 | Heterocyclic compounds | ZENECA LTD (GB) | 1995-07-12 | — | — | EP | claimed |
| EP-0434341-B1 | Diazine derivatives | ZENECA LTD (GB) | 1995-05-17 | — | — | EP | claimed |
| US-5252567-A | Cardiovascular disorders, sino-atrial node effects | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-10-12 | — | — | US | claimed |
| EP-0434341-A1 | Diazine derivatives | ZENECA LIMITED (GB) | 1991-06-26 | — | — | EP | claimed |
| EP-0431856-A2 | Heterocyclic compounds | ZENECA LIMITED (GB) | 1991-06-12 | — | — | EP | claimed |
| US-4925849-A | DIURETICS, HYPOTENSIVE AGENTS, CARIOTONIC AGENTS AND ANTIEDEMIC AGENTS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-05-15 | — | — | US | claimed |
| EP-0163416-B1 | PHENOL DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-05-31 | — | — | EP | claimed |
| EP-0299209-A2 | Pyrazolopyridine compound and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-01-18 | — | — | EP | claimed |
| US-4057552-A | AMMONIATION, OXIDIZED VANADIUM OXIDE ON SUPPORT AS CATALYST | THE LUMMUS COMPANY (US) | 1977-11-08 | — | — | US | claimed |